Detalhe da pesquisa
1.
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
Cancer Immunol Immunother
; 67(12): 1853-1862, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209589